Area of research
Hematology · Genetics
Research interest
Research interests include Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, and Hematological disorders and diagnostics.
Cure of intravascular NK/T-cell lymphoma of the central nervous system by allogeneic hematopoietic cell transplantation
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
Oncogene-induced senescence: a potential breakpoint mechanism against malignant transformation in plasma cell disorders
Influence of Regioselectively Sulfated Cellulose on in Vitro Vascularization of Biomimetic Bone Matrices
Profiling of Oncogenic Signaling in Multiple Myeloma — Association with Biology, Disease Progression and Prognosis
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib
Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition
Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy
Abstract 2283: Molecular signaling in multiple myeloma: association of RAS/RAF mutation status and MAPK pathway activation in primary myeloma patient biopsies
Prospective Investigation of Genetic Alterations in Osteolytic Lesions Compared to Paired Random Aspirates
Recurrent CDKN1B (p27) mutations in hairy cell leukemia
Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility
Aggressive primary cutaneous B‐cell lymphomas show increased Angiopoietin‐2‐induced angiogenesis
Targeted sequencing of relapsed/refractory myeloma patients identifies an enrichment of mutations in MAPK and Cereblon pathways
Abstract 2423: Signaling pathway profiling in multiple myeloma
Targeted Sequencing of Relapsed/Refractory Myeloma Patients Identifies an Enrichment of Mutations in Cereblon and MAPK Pathways
Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia
Infiltration patterns in monoclonal plasma cell disorders: correlation of magnetic resonance imaging with matched bone marrow histology
BRAF Inhibition in Hairy Cell Leukemia: Multicentre Experience of 21 Patients Treated with Vemurafenib
Signaling Pathway Profiling in Multiple Myeloma
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
Targeting the BRAF V600E Mutation in Multiple Myeloma
Continued Response Off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia
The Glycome of Normal and Malignant Plasma Cells
Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseases